The Science
This page explains the science of CAR-T cell therapy, including its mechanism of action and the structure of 4-1BB CAR-T cells, as well as efficacy, safety, and patient identification.
The Process
This page explains the manufacturing process of CAR-T cell therapy, including details such as leukapheresis, cryopreservation, and outpatient administration.
The Landscape
This page details the current landscape of treatment options for patients with haematologic malignancies, outlining key details about CAR-T cell therapy and standards of care such as stem cell transplant and cycling chemotherapy.
The Pioneers
This page outlines the Novartis CAR-T legacy, explaining the history of CAR-T cell therapy and future areas for exploration.